anti-JNK therapy (Garvan Institute of Medical Research)

N/A

Report date: 2025/03/14 16:55:40
NME

Base Information

Drug Nameanti-JNK therapy (Garvan Institute of Medical Research)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGarvan Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesGarvan Institute Of Medical Research
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A